Skip to main content

Site notifications

(Approval lapsed) Cisatracurium 2mg/ml (20mg/10ml) solution for injection/infusion (Noridem Enterprises)

Section 19A approved medicine
(Approval lapsed) Cisatracurium 2mg/ml (20mg/10ml) solution for injection/infusion (Noridem Enterprises)
Section 19A approval holder
Juno Pharmaceuticals Pty Ltd ABN 55 156 303 650
Phone
03 8888 1288
Approved until
Status
Expired
Medicines in short supply/unavailable
NIMBEX cisatracurium (as besilate) 5mg/2.5mL injection ampoule - ARTG 55913
CISATRACURIUM JUNO 5 mg / 2.5 mL solution for injection ampoule - ARTG 226854 (MS-2020-NT-01127-1)
CISATRACURIUM JUNO 10 mg / 5mL solution for injection ampoule - ARTG 226857 (MS-2020-NT-01128-1)
CISATRACURIUM JUNO 150 mg /30 mL solution for injection vial - ARTG 226859 (MS-2020-NT-01129-1)
DBL CISATRACURIUM INJECTION CONCENTRATE cisatracurium (as besilate) 10 mg/5 mL solution for injection vial - ARTG 170580
DBL CISATRACURIUM INJECTION CONCENTRATE cisatracurium (as besilate) 5 mg/2.5 mL solution for injection vial - ARTG 170579
Indication(s)

For use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. It is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Help us improve the Therapeutic Goods Administration site